Grade My Investments

OPKO Health, Inc. (OPK) Stock Grade

OPK · Healthcare

C
Grade updated: July 18, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$946.4M
P/E Ratio
Revenue Growth (YoY)
-14.9%
Net Margin
-37.2%
Return on Equity
Dividend Yield
None

About OPKO Health, Inc.'s fundamentals

OPKO Health is a biotechnology company with a market capitalization of $946.4 million that is currently unprofitable, reporting a net loss in its latest annual statement with a net margin of -37.2%. The company experienced a significant revenue contraction of 14.9% year-over-year, indicating declining sales momentum. OPKO does not pay a dividend and lacks a meaningful P/E ratio due to its loss-making status. The combination of negative profitability, shrinking revenue, and absence of shareholder distributions suggests the company is in an investment recovery phase.

Track OPK free — no credit card required. Live grade + monthly AI report →